Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so
admin 2nd April 2019 Uncategorised 0Puma Biotech has been a permanent subject of takeover gossip. But whatever M&A hope investors previously had for a buyout, a European Nerlynx licensing deal may have shattered it. More: Is Puma off the cancer M&A list? With Nerlyx marketing
read more